Pages that link to "Q43187349"
Jump to navigation
Jump to search
The following pages link to Aurora kinase inhibitor AZD1152 negatively affects the growth and survival of HTLV-1-infected T lymphocytes in vitro (Q43187349):
Displaying 9 items.
- Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia (Q34293391) (← links)
- The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma. (Q35664956) (← links)
- The potential role of Aurora kinase inhibitors in haematological malignancies (Q37167047) (← links)
- Aurora kinase inhibitor patents and agents in clinical testing: an update (2009-10). (Q37876882) (← links)
- Human T-lymphotropic virus proteins and post-translational modification pathways (Q38156859) (← links)
- Cooperative phosphorylation of FADD by Aur-A and Plk1 in response to taxol triggers both apoptotic and necrotic cell death (Q39462162) (← links)
- A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemia (Q54590599) (← links)
- Prominent apoptosis in pautrier microabscesses: a distinctive finding in adult T-cell leukemia/lymphoma? (Q84132697) (← links)
- Wikidata:WikiCite/Wikidata lists/Items about HTLV-1 (← links | edit)